A new online learning series for ERN professionals, clinicians, researchers, and stakeholders.

Advancing Rare Disease Diagnostics: The ERDERA Diagnostic Research Workstream Webinar Series

ERDERA trainings diagnostics

As part of its Education and Training offering, ERDERA is launching a dedicated webinar series designed to inform and engage the wider rare disease community: the ERDERA Diagnostic Research Workstream Webinar Series.

About the series

The series brings together ERN healthcare professionals, clinicians, geneticists, researchers, and other stakeholders to learn about the work, progress, and outcomes of the ERDERA Diagnostic Research Workstream (DRW).

Sessions will cover the full scope of the workstream — from governance and methodology to concrete analytical results — offering audiences a transparent and evolving view of how ERDERA is advancing diagnostics in rare diseases.

Delivered as online webinars, the series is accessible to both internal ERN audiences and external expert communities, reflecting ERDERA’s commitment to open knowledge-sharing and collaboration across borders.

What to expect

Eight webinars are planned between May 2026 and June 2027, each focused on a distinct aspect of the Diagnostic Research Workstream:

ERDERA Diagnostic Research Workstream Webinar Series — planned sessions
# Title Topic Speakers Date Event link
1
The ERDERA Diagnostic Research Workstream – An Overview
General overview of the DRW Holm Graessner 28 May 2026 View event
2 Data sharing, data management & ethics DSFA, ethics, data submission, data flow, RD3 Kornelia Ellwanger, Leslie Matalonga September 2026 Register here
3 The data reanalysis approach of the Diagnostic Research Workstream Tiered approach, DITF-DATF structure, Solvathon concept Lisenka Vissers October 2026 Link coming soon
4 Long-read sequencing and Optical Genome Mapping WP8 long-read sequencing and OGM Bart van der Sanden, Alexander Hoischen, Stephan Ossowski / Tobias Haack (tbc) December 2026 Link coming soon
5 Results of the systematic reanalysis Results of data reanalysis Tier 1 Sergi Beltran, Gemma Bullich, Lisenka Vissers February 2027 Link coming soon
6 First results from our innovative reanalysis approach Results of data reanalysis Tier 2 Sergi Beltran, Gemma Bullich April 2027 (tbc) Link coming soon
7 Scaling-up: from distributed to federated reanalysis Distributed vs. federated approach Sergi Beltran, Morris Swertz, Julien Thevenon (tbc) May 2027 Link coming soon
8 Reanalysis of RNAseq data RNAseq reanalysis results Vicente Yépez June 2027 Link coming soon

Note: Dates marked (tbc) are preliminary and subject to change.

Themes at a glance

Across the eight sessions, the series traces the full arc of the Diagnostic Research Workstream’s activities. Early webinars introduce governance structures, ethical frameworks, and data management principles. Middle sessions delve into methodological innovation — including tiered reanalysis strategies, long-read sequencing, and optical genome mapping. Later webinars focus on results, first from systematic Tier 1 reanalysis and then from more advanced approaches.

Details on registration and attendance of each of the webinar will be made available through ERDERA’s official channels, including this page, closer to the date.

News & Updates

You might also be interested in

September 25 @ 1:00 pm - 2:00 pm
Intended for researchers, clinicians, data managers, ERN and National Mirror Group members involved in or interested in ERDERA diagnostic research.
By connecting national priorities with European initiatives, NMGs support stronger coordination, knowledge exchange and alignment across the rare disease ecosystem.
The multicentre observational study analysed 661 assessments from 219 people with SCA27B to examine disease progression, clinical outcome metrics and demographic or genetic modifiers.
At the “Advancement of Treatments for Rare Diseases” conference in Nicosia, European and national policymakers joined clinicians, researchers, regulators, industry representatives and patient advocates to examine how stronger coordination can translate scientific progress into better prevention, diagnosis, treatment and access to care for people living with rare diseases.